- Post-Effective Amendment to an S-8 filing (S-8 POS)
31 Março 2009 - 7:05AM
Edgar (US Regulatory)
Registration
Nos.
333-85270,
333-118022, 333-123536, 333-150124, 333-151469, 333-151495
As
filed with the Securities and Exchange Commission on March 30, 2009
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-8 POS
(POST-EFFECTIVE
AMENDMENT NO. 1)
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF 1933
___________________________________________
PHARMANET
DEVELOPMENT GROUP, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
59-2407464
|
|
(State
or other jurisdiction of incorporation or organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
504 Carnegie
Center
Princeton,
NJ 08540
|
|
(Address
of Principal Executive Offices including Zip
Code)
|
|
Second
Amended and Restated 1999 Stock Option Plan and Stock Option
Agreements
2004
Employee Stock Purchase Plan
2004
Acquisition Stock Option Plan
2004
Employee Stock Purchase Plan, as amended and restated
PharmaNet
Development Group 2008 Incentive Compensation Plan
2008 International Employee Stock
Purchase Plan
|
|
(Full
title of the plan)
|
|
Steven
J. Daniels, Esq.
Skadden,
Arps, Slate, Meagher & Flom LLP
One
Rodney Square
P.O.
Box 636
Wilmington,
Delaware 19899
Tel:
302-651-3000
|
|
(Name,
address, including zip code, and telephone number, including area code, of
agent for service)
|
TERMINATION OF
REGISTRATION
This Post-Effective Amendment relates
to the following Registration Statements on Forms S-8 (collectively, the
“Registration Statements”) filed by PharmaNet Development Group, Inc. (formerly
known as SFBC International, Inc.) with the Securities and Exchange
Commission:
1. Registration
No. 333-85270, filed on April 1, 2002, pertaining to shares of common stock to
be offered under the Second Amended and Restated 1999 Stock Option Plan and
Stock Option Agreements;
2. Registration
No. 333-118022, filed on August 6, 2004, pertaining to shares of common stock to
be offered under the 2004 Employee Stock Purchase Plan;
3. Registration
No. 333-123536, filed on March 24, 2005, pertaining to shares of common stock to
be offered under the 2004 Acquisition Stock Option Plan;
4. Registration
No. 333-150124, filed on April 7, 2008, pertaining to shares of common stock,
including Preferred Stock Purchase Rights, to be offered under the 2004 Employee
Stock Purchase Plan, as amended and restated;
5. Registration
No. 333-151469, filed on June 6, 2008, pertaining to shares of common stock,
including Preferred Stock Purchase Rights, to be offered under the PharmaNet
Development Group 2008 Incentive Compensation Plan;
6. Registration
No. 333-151495, filed on June 6, 2008, pertaining to shares of common stock,
including Preferred Stock Purchase Rights, to be offered under the 2008
International Employee Stock Purchase Plan and 2004 Employee Stock Purchase
Plan, as amended and restated;
The undersigned hereby removes and
withdraws from registration all securities registered pursuant to the
Registration Statements that remain unsold.
SIGNATURES
Pursuant to the requirements of the
Securities Act of 1933, as amended, PharmaNet Development Group, Inc. certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Post-Effective Amendment to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Princeton, state of New Jersey, on the 30
th
day of
March, 2009.
|
|
PHARMANET
DEVELOPMENT GROUP, INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/
John
P. Hamill
|
|
|
|
Name:
John P. Hamill
Title:
Chief Financial Officer
Date:
March 30, 2009
|
Pursuant
to the requirements of the Securities Act of 1933, as amended, this
post-effective amendment to the Registration Statement has been signed by the
following persons in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/
Jeffrey P. McMullen
Jeffrey
P. McMullen
|
|
President
and Chief Executive Officer, Director
(Principal
Executive Officer)
|
|
March
30, 2009
|
|
|
|
|
|
|
|
/s/
John
P. Hamill
John
P. Hamill
|
|
Executive
Vice President and Chief Financial Officer
(Principal
Financial and Accounting Officer)
|
|
March
30, 2009
|
|
|
|
|
|
|
|
/s/ PAUL S.
LEVY
Paul
S. Levy
|
|
Director
|
|
March
30, 2009
|
|
|
|
|
|
|
|
/s/ RAMSEY A.
FRANK
Ramsey
A. Frank
|
|
Director
|
|
March
30, 2009
|
|
|
|
|
|
|
|
/s/ THOMAS S.
TAYLOR
Thomas
S. Taylor
|
|
Director
|
|
March
30, 2009
|
|
|
|
|
|
|
|
/s/ PETER M.
STROTHMAN
Peter
M. Strothman
|
|
Director
|
|
March
30, 2009
|
4
Pharmanet Development Grp (MM) (NASDAQ:PDGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Pharmanet Development Grp (MM) (NASDAQ:PDGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
